Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

Université Laval

$45,000.00

Chemogenetic mapping of primate brain function

FY 2024-25

Summary
This proposal outlines an ambitious research program to develop chemogenetic techniques for the nonhuman primate brain. Chemogenetics is a cutting-edge method that allows researchers to precisely manipulate neuronal activity using genetically-encoded synthetic receptors that are activated by designer drugs. Although chemogenetics has been transformational in small animal models like mice, it requires substantial optimization before it can be reliably deployed in nonhuman primates. Using chemogenetic tools in conjunction with exhaustive, automated neuropsychological testing, the long-term objective of this program is to create the first `causal map' of primate cortex function. In the short term, the program will first aim to optimize viral vector constructs to efficiently deliver and express chemogenetic receptors, such as DREADDs and PSAMs, in cortical neurons of the macaque prefrontal cortex. Viral constructs differing in serotype, promoter, chemogenetic gene, and titer will be locally injected in the prefrontal cortex of two subjects using state-of-the-art MRI-guided neurosurgical techniques. The efficacy and specificity of the viral transduction will be thoroughly evaluated post-mortem using histological quantification. Expression assays will also be developed in vivo using PET imaging with a radiolabeled version of the chemogenetic actuators. The best performing vectors will subsequently be used to express chemogenetic receptors in prefrontal area 8A of two macaques. After a 4-week incubation period, Utah multielectrode arrays will be chronically implanted in area 8A to record population neural activity during chemogenetic inhibition. Electrophysiological analyses will document the time-course, magnitude, and reversibility of neural modulation on large ensembles of single neurons. Finally, the same implanted monkeys will be trained to perform a cognitive task known to causally depend on area 8A using an automated in-cage testing apparatus my group developed. Chemogenetic inhibition of 8A is expected to induce a temporary yet reversible impairment in the monkeys' performance, analogous to permanent lesion effects reported previously. Systematically varying the dose and route of administration for the chemogenetic actuator will allow identifying optimal experimental parameters for cognitive control. This ambitious research program promises to establish chemogenetics as a new technique to remotely control neural activity in primates with unprecedented precision. By combining chemogenetics with automated cognitive testing, the pace of discovery in cognitive neuroscience will accelerate dramatically. Given the extensive homologies between human and monkey brains, the resulting functional insights will help elucidate human brain organization as well. Beyond its scientific contributions, the highly interdisciplinary training environment created by this program will prepare the next generation of students for the future of neuroscience research.
Program
Discovery Grants Program - Individual
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2024-04067
Name nom
Tremblay, Sébastien
Department département
Psychiatry and Neuroscience
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
45000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Chemogenetic mapping of primate brain function
Keywords
chemogenetics; nonhuman primates; cognitive functions; macaque monkeys; brain mapping; causal inference; vectorology; neurosurgery; neuropsychology
Application summary
This proposal outlines an ambitious research program to develop chemogenetic techniques for the nonhuman primate brain. Chemogenetics is a cutting-edge method that allows researchers to precisely manipulate neuronal activity using genetically-encoded synthetic receptors that are activated by designer drugs. Although chemogenetics has been transformational in small animal models like mice, it requires substantial optimization before it can be reliably deployed in nonhuman primates. Using chemogenetic tools in conjunction with exhaustive, automated neuropsychological testing, the long-term objective of this program is to create the first `causal map' of primate cortex function. In the short term, the program will first aim to optimize viral vector constructs to efficiently deliver and express chemogenetic receptors, such as DREADDs and PSAMs, in cortical neurons of the macaque prefrontal cortex. Viral constructs differing in serotype, promoter, chemogenetic gene, and titer will be locally injected in the prefrontal cortex of two subjects using state-of-the-art MRI-guided neurosurgical techniques. The efficacy and specificity of the viral transduction will be thoroughly evaluated post-mortem using histological quantification. Expression assays will also be developed in vivo using PET imaging with a radiolabeled version of the chemogenetic actuators. The best performing vectors will subsequently be used to express chemogenetic receptors in prefrontal area 8A of two macaques. After a 4-week incubation period, Utah multielectrode arrays will be chronically implanted in area 8A to record population neural activity during chemogenetic inhibition. Electrophysiological analyses will document the time-course, magnitude, and reversibility of neural modulation on large ensembles of single neurons. Finally, the same implanted monkeys will be trained to perform a cognitive task known to causally depend on area 8A using an automated in-cage testing apparatus my group developed. Chemogenetic inhibition of 8A is expected to induce a temporary yet reversible impairment in the monkeys' performance, analogous to permanent lesion effects reported previously. Systematically varying the dose and route of administration for the chemogenetic actuator will allow identifying optimal experimental parameters for cognitive control. This ambitious research program promises to establish chemogenetics as a new technique to remotely control neural activity in primates with unprecedented precision. By combining chemogenetics with automated cognitive testing, the pace of discovery in cognitive neuroscience will accelerate dramatically. Given the extensive homologies between human and monkey brains, the resulting functional insights will help elucidate human brain organization as well. Beyond its scientific contributions, the highly interdisciplinary training environment created by this program will prepare the next generation of students for the future of neuroscience research.